Keywords: Pfizer, Celebrex, Patent reissue, USA, USPTO, Osteoarthritis, Teva, Mylan, Watson, Lupin, Apotex

USPTO grants Pfizer reissue patent for Celebrex, extending term to Dec 2015

Article | 06 March 2013

Print This

Global pharma behemoth Pfizer (NYSE: PFE) said yesterday that the US Patent & Trademark Office has granted the company a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in